Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Vivani Medical (U5P) Price & Analysis

U5P Stock Chart & Stats

€0.94-€0.03(-3.61%)
At close: 4:00 PM EDT
EUR 0.975EUR 1EUR 1.025EUR 1.0524 Sep20 Oct
Day’s Range
EUR 0.94 - EUR 0.94
52-Week Range
EUR 0.74 - EUR 1.40
Previous Close
EUR 0.97
Volume
0
Average Volume (3M)
17
Market Cap
EUR 87.74M
Enterprise Value
EUR 105.99M
Total Cash (Recent Filing)
EUR 19.89M
Total Debt (Recent Filing)
EUR 17.86M
Price to Earnings (P/E)
―
Beta
0.68
Next Earnings
Nov 18, 2026
EPS Estimate
-0.08
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Implantable Drug-delivery Platform

The implant platform targets a persistent treatment challenge in chronic disease: maintaining consistent dosing over time. If clinical development succeeds, sustained delivery could support adherence and differentiate Vivani’s products from more frequent dosing approaches.

Clinical Execution

Completing the Phase 1 trial ahead of schedule demonstrates operational execution and moves NPM-139 toward top-line data, an IND filing, and a planned Phase 2 study. These milestones can increase the program’s development value over the next several quarters.

External Validation From Novo Nordisk

Novo Nordisk’s evaluation agreement provides external validation for Vivani’s semaglutide implant and NanoPortal technology. While non-exclusive and not a commercial partnership, the arrangement may support credibility and inform future strategic development of the platform.

Bears Say

No Commercial Revenue

The absence of revenue means Vivani has not yet demonstrated commercial demand or operating leverage. Persistent losses also indicate that the business remains dependent on successful clinical development and future financing before it can establish a self-sustaining earnings base.

Heavy Cash Burn

Sustained negative operating and free cash flow requires Vivani to fund ongoing research and corporate activity from existing liquidity or external capital. Continued cash burn can reduce strategic flexibility and increase the importance of upcoming clinical and financing milestones.

Meaningful Leverage

Debt approaching the level of equity adds financial pressure to an already loss-making development-stage company. If additional funding is needed, existing leverage may constrain choices, increase financing risk, and raise the potential for shareholder dilution.

Vivani Medical News

U5P FAQ

What was Vivani Medical’s price range in the past 12 months?
Vivani Medical lowest stock price was €0.74 and its highest was €1.40 in the past 12 months.
What is Vivani Medical’s market cap?
Vivani Medical’s market cap is €87.74M.
When is Vivani Medical’s upcoming earnings report date?
Vivani Medical’s upcoming earnings report date is Nov 18, 2026 which is in 17 days.
How were Vivani Medical’s earnings last quarter?
Vivani Medical released its earnings results on Aug 13, 2026. The company reported -€0.062 earnings per share for the quarter, beating the consensus estimate of -€0.074 by €0.012.
Is Vivani Medical overvalued?
According to Wall Street analysts Vivani Medical’s price is currently Undervalued.
Does Vivani Medical pay dividends?
Vivani Medical does not currently pay dividends.
What is Vivani Medical’s EPS estimate?
Vivani Medical’s EPS estimate is -0.08.
How many shares outstanding does Vivani Medical have?
Vivani Medical has 90,203,354 shares outstanding.
What happened to Vivani Medical’s price movement after its last earnings report?
Vivani Medical reported an EPS of -€0.062 in its last earnings report, beating expectations of -€0.074. Following the earnings report the stock price went down -1.835%.
Which hedge fund is a major shareholder of Vivani Medical?
Currently, no hedge funds are holding shares in DE:U5P
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology